As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...
Empirical Bayes is a versatile approach to “learn from a lot” in two ways: first, from a large number of variables and, second, from a potentially large amount of prior information, for example, ...
The Annals of Applied Statistics, Vol. 14, No. 1 (March 2020), pp. 241-256 (16 pages) ABOUZAHR, C., CLELAND, J., COULLARE, F., MACFARLANE, S. B., NOTZON, F. C., SETEL ...
However, traditional clinical trial designs are often ill-suited for rare disease research with common challenges including ...
Dr. James McCaffrey of Microsoft Research says the main advantage of using Gaussian naive Bayes classification compared to other techniques like decision trees or neural networks is that you don't ...
Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results